Cisplatin 10 mg/10 mL
| Product Overview | |
| Generic Name | Cisplatin 10 mg/10 mL |
| Brand Name(s) | Cislieva, Kemoplat, Platinex |
| Form | Aqueous IV injection, vial |
| Strength | 10 mg in 10 mL (1 mg/mL) |
| Therapeutic Class | Platinum-based alkylating agent |
| ATC Code | L01XA01 |
| Manufacturing & Regulatory | |
| Manufacturer | Allieva Pharma, Venus Remedies |
| Country | Canada, USA, India |
| GMP Compliance | WHO/GMP-compliant |
| DMF/CEP | manufacturer-specific, not publicly listed |
| COFEPRIS | 010.000.3046.00 |
| Free Sale Certificate | Available per batch upon request |
| Logistics & Export | |
| MOQ | 10 Vials |
| Shelf Life | 36 months |
| Storage | 2–8 °C to 25 °C; store in cool, dry, protected from light |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 10 Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon supply |
| SDS | Available from manufacturer |
| CTD Summary | CTD for originator; abbreviated CTD for generics |
Description
Cisplatin is an injectable platinum-based chemotherapy medicine used under specialist oncology supervision for the treatment of several solid tumors, including testicular, ovarian, bladder, lung, cervical, and head-and-neck cancers. It is administered by intravenous infusion and requires close monitoring due to potential kidney toxicity, bone marrow suppression, hearing toxicity, nausea/vomiting, and electrolyte abnormalities.
